Skip to content

Risk of Hospitalized Bacterial Infections associated with Biologics Treatmentfor Rheumatoid Arthritis Patients: A real registry study.

Risk of Hospitalized Bacterial Infections associated with Biologics Treatmentfor Rheumatoid Arthritis Patients: A real registry study. - Safety of biologics treatment for rheumatoid arthritis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016412
Enrollment
1500
Registered
2015-10-01
Start date
2014-04-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Sponsors

National Hospital Organization, Kumamoto Saishunsou National Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Rheumatoid arthritis patients who first treated with biologics between 2009 Jan 1 and 2014 Dec 31.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Hosiptalized bacterial ingections

Countries

Japan

Contacts

Public ContactShunsuke Mori

National Hospital Organization, Kumamoto Saishunsou National Hospital Center for Rheumatic Disease

moris@saisyunsou1.hosp.go.jp81-96-242-1000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026